ANTITUMOR AGENTS .1. DNA TOPOISOMERASE-II INHIBITORY ACTIVITY AND THE STRUCTURAL RELATIONSHIP OF PODOPHYLLOTOXIN DERIVATIVES AS ANTITUMOR AGENTS

被引:34
作者
TERADA, T
FUJIMOTO, K
NOMURA, M
YAMASHITA, J
KOBUNAI, T
TAKEDA, S
WIERZBA, K
YAMADA, Y
YAMAGUCHI, H
机构
[1] TAIHO PHARMACEUT CO LTD, RES INST, TOKUSHIMA 77101, JAPAN
[2] OSAKA UNIV PHARMACEUT SCI, OSAKA 580, JAPAN
关键词
ANTITUMOR AGENT; SYNTHESIS; STRUCTURAL RELATIONSHIP; INVIVO; INVITRO; DNA TOPOISOMERASE-II; CYTOTOXICITY; TUBULIN POLYMERIZATION; PODOPHYLLOTOXIN DERIVATIVE; DEOXYPODOPHYLLOTOXIN;
D O I
10.1248/cpb.40.2720
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Various podophyllotoxin derivatives from desoxypodophyllotoxin (DPT) were synthesized to examine the structural relationships between the biological significance (cytotoxic effect, effects on DNA topoisomerase II and tubulin polymerization) in vitro and antitumor activity in vivo (L 1210). An intact 6,7-methylenedioxy group of DPT is necessary to inhibit tubulin polymerization and topoisomerase II. 4'-Phenolic hydroxyl group of DPT is essential to inhibit DNA topoisomerase II and the inhibitory effect on DNA topoisomerase II contributes to a high cytotoxicity. The introduction of an aminoalkoxy group at 1-position of DPT enhances the inhibitory activity against DNA topoisomerase II and cytotoxic effect, causing the inhibitory activity against tubulin polymerization to disappear. The results of antitumor test in mice bearing L 1210 on podophyllotoxin derivatives suggest the following: 1) the strong cytotoxic effect itself is not a good indication of antitumor activity in vivo as long as it is associated with inhibition of tubulin polymerization. DNA topoisomerase II inhibitory effect contributes to an antitumor activity in vivo; 2) detailed measurements of cytotoxicity and inhibition on DNA topoisomerase II and tubulin polymerization in vitro are necessary to evaluate podophyllotoxin derivatives.
引用
收藏
页码:2720 / 2727
页数:8
相关论文
共 34 条
[1]   ANTITUMOR AGENTS .99. SYNTHETIC RING C AROMATIZED PODOPHYLLOTOXIN ANALOGS AS POTENTIAL INHIBITORS OF HUMAN DNA TOPOISOMERASE-II [J].
BEERS, SA ;
IMAKURA, Y ;
DAI, HJ ;
LI, DH ;
CHENG, YC ;
LEE, KH .
JOURNAL OF NATURAL PRODUCTS, 1988, 51 (05) :901-905
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
COHEN MH, 1977, CANCER TREAT REP, V61, P489
[4]  
DEFFIE AM, 1989, CANCER RES, V49, P58
[5]   DNA TOPOISOMERASES FROM RAT-LIVER - PHYSIOLOGICAL VARIATIONS [J].
DUGUET, M ;
LAVENOT, C ;
HARPER, F ;
MIRAMBEAU, G ;
DERECONDO, AM .
NUCLEIC ACIDS RESEARCH, 1983, 11 (04) :1059-1075
[6]  
FALKSON G, 1964, AFR J RADIOL, V2, P1
[7]   NON-ENOLIZABLE PODOPHYLLOTOXIN DERIVATIVES [J].
GENSLER, WJ ;
MURTHY, CD ;
TRAMMELL, MH .
JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (05) :635-644
[8]   CHARACTERIZATION OF VP-16-INDUCED DNA DAMAGE IN ISOLATED-NUCLEI FROM L1210 CELLS [J].
GLISSON, BS ;
SMALLWOOD, SE ;
ROSS, WE .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 783 (01) :74-79
[9]   THE STRUCTURE OF SILICICOLIN [J].
HARTWELL, JL ;
SCHRECKER, AW ;
JOHNSON, JM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1953, 75 (09) :2138-2140
[10]  
ISSELL BF, 1982, CANCER CHEMOTH PHARM, V7, P73